Crowdonomics
This isn’t HyperSciences’s most recent raise. Reg CF · Preferred Stock · Mar 2022 (Closed) is more current.View latest round
HyperSciences

Reg A+ · Common Stock · Apr 2018

ClosedReached targetReg A+Common Equity
via SI Securities, LLCView campaign
Raised
$9.2M / $10M max
92% of ceiling
Investors
—
—
Estimated pre-money
$20.7M
—

Financials disclosed in this offering

FY2017 · hover for source
$0
−$1.5M
FY2017
RevenueNet income
Metric
FY2017 audited
Income statement
Revenue
$0
Cost of goods sold
$0
Net income
-$1,492,072
Balance sheet
Cash
$290
Accounts receivable
$0
Total assets
$325,323
Long-term debt
$564,114
Total liabilities
$4,153,683
Other
Headcount
1

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

4 amendments
  1. Jun 27, 2018
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  2. Jun 26, 2018
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  3. Jun 20, 2018
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  4. Jun 5, 2018
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. Form 1-A amendments state no reason; those filed before qualification are usually responses to SEC staff review.

Deal terms

Est. pre-money$20.7M
Price / share$3.84
Shares offered2,604,166

Estimated, not stated: $3.84 × 5,397,727 securities outstanding.

Offering details

Target$2,500,000
Max$10,000,000
Min investment—
OpenedApr 30, 2018
DeadlineJan 13, 2021
ClosedApr 29, 2021
Days active1,095

Links & provenance

Source: Manual
0001052918-18-000139

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.